Maximum efficacy was observed at 12mg with 24.2% average weight loss
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey J-N, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, Bchler MW, Weitz J (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery
Even though higher doses of oral semaglutide (25 mg and 50 mg) can achieve similar HbA 1c and weight reductions to orforglipron, the convenience of unrestricted daily orforglipron dosing means this is likely to be more attractive to people requesting an oral drug, depending on whether cardiovascular benefits are observed in the outcomes study
Furthermore, both the comparative lean mass and the underlying fat mass in all groups linked with the peptide seemed to stay consistent with control measurements in normal murine models